Clinical Expertise

The faculty is highly experienced in performance of anatomical radical prostatectomy which offers lowest blood loss, more rapid return of continence, and nerve sparing maintenance of potency in the maximum number of patients. There is an established radiation therapy program which includes external beam and interstitial brachytherapy. The Department is an early leader in the development of laparoscopic radical prostatectomy as an alternative to other traditional means of treatment. There is a long experience with multidisciplinary use of hormonal therapy (androgen blockade) and systemic chemotherapy for advanced disease. The faculty are frequently invited speakers and authors on these topics.

Clinical Research

• Chemoprevention Trials

          PCPT (enrollment complete)- Proscar vs.

          Placebo

          SELECT- Selenium, Vit E vs. Placebo

• Trials for Advanced “Hormone Refractory” Disease

          Atrasetan (Endothelin Receptor Blocker)

          Novel use of DES combinations

          Systemic Chemotherapy

• Developmental Treatment Algorithms for PSA Relapse

Basic Science Research

• Mechanisms of Hormone Refractory Disease
• Mechanisms and Potential for Gene Therapy
• Methylation Defects in Tumors

For more information about the Department of Urology, contact:

Phone: 214-648-4765, FAX: 214-648-4789

Mailing Address:  5323 Harry Hines Blvd., J8.148, Dallas, TX  75390-9110